
To guarantee the highest purity and efficacy, we adhere to strict global standards
Lincomycin is a foundational antibiotic belonging to the Lincosamides class. It is characterized by its directed effectiveness against a wide spectrum of Gram-positive aerobic and anaerobic bacteria, including common pathogens like Staphylococci and Streptococci. We supply Lincomycin in its Hydrochloride (HCl) salt form, which features high water solubility, making it ideal for injectable and liquid oral formulations, including both human and veterinary applications.
Sterile solutions for intramuscular (IM) or intravenous (IV) injection (for both human and veterinary use).
The high solubility of the HCl salt and the availability of high-purity grades meet strict sterility requirements.
Oral tablets and capsules.
Good powder flow and compressibility characteristics for standard tableting and filling processes.
Oral solutions and syrups (especially for veterinary use).
Excellent stability in aqueous solutions, facilitating the manufacture of liquid products with long shelf lives.
The product conforms to the specified requirements of the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and/or British Pharmacopoeia (BP).
A detailed CoA is issued with every batch, outlining potency, purity profile, and microbiological testing verification.
A comprehensive Drug Master File is available to support registration submissions to regulatory authorities worldwide.
Production takes place in certified facilities that strictly adhere to current Good Manufacturing Practices (cGMP).